Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain (abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18666769
Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain (full – 2010)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253719/
Studies demonstrate analgesic properties of synthetic cannabinoid (news – 2010) http://www.news-medical.net/news/201...nnabinoid.aspx
Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain (full – 2010)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253719/
Studies demonstrate analgesic properties of synthetic cannabinoid (news – 2010) http://www.news-medical.net/news/201...nnabinoid.aspx